Discovery and Optimization of Tetrahydroisoquinoline Derivatives To Enhance Lysosome Biogenesis as Preclinical Candidates for the Treatment of Alzheimer's Disease

Jianhui Zhou,Ning Wang,Mengxue Wang,Yuting Hu,Zhenwei Zhang,Zhiyong Gu,Jing Wang,Haowen Shou,Xi Cheng,Hong Liu,Yang Li,Yu Zhou
DOI: https://doi.org/10.1021/acs.jmedchem.4c00159
IF: 8.039
2024-06-05
Journal of Medicinal Chemistry
Abstract:More than 55 million individuals are suffering from Alzheimer's disease (AD), while the effective therapeutic strategies remain elusive. Our previous study identified a lysosome-enhancing lead compound LH2-051 with a tetrahydroisoquinoline scaffold through a novel dopamine transporter-cyclin-dependent kinase 9-transcription factor EB (DAT-CDK9-TFEB) regulation mechanism to promote TFEB activation and lysosome biogenesis. Here, we launched a comprehensive structure-activity relationship study for...
chemistry, medicinal
What problem does this paper attempt to address?